ms and tirzepatide In adults with obesity but not diabetes, leads to significantly greater weight loss than semaglutide over 72 weeks, nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms .spr.ly/6183SkuIL Tirzepatide Treatment in Southaven, MS

Factors that influence outcomes include starting weight, metabolic health, adherence to dietary recommendations, physical activity level, and individual medication response

Allergic reaction: Symptoms include swelling of the face, lips, tongue, or throat, difficulty breathing or swallowing, or a rapid heartbeat

These benefits and the increase in energy can make it easier for individuals to implement positive lifestyle changes, such as adherence to an exercise regimen, which facilitates further weight loss

Not as powerful as tirzepatide or retatrutide in head-to-head data

The STEP 4 trial tested exactly this

Tirzepatide: Good lipid responses and high reduction in HbA1c (to 2.4 percent)